(0) items in cart / view cart / checkout  
 
  Chemicals
  Company Profiles
  Country Analyses
  Energy and Utilities
  Food & Beverage
  In Vitro Diagnostics
  Medical Devices
  Pharmaceuticals & Biotechnology
 
 
  Advertising
Aerospace, Defense
Automotive
Banking
Biotechnology
Business Services
Chemicals
Company Reports
Construction
Consumer Goods
Countries
Diagnostics
Energy, Environment
Food & Beverages
Government
Healthcare
IT
Manufacturing
Media
Medical Devices
Pharmaceuticals
Retailing
Sales & Marketing
Sourcing
Telecommunications
Transportation
Travel, Entertainment
 
Home > In Vitro Diagnostics >  Infectious Diseases
 
 Infectious Diseases Market Research Reports
Title

To order sections of the reports, contact Client Services.

Price
« Previous  1  2  3  4  5  6  7  8  9  10  Next »
Middle East Infectious Disease Testing Market: Sales and Volume Forecasts for 100 Microbiology Tests, Competitive Strategies, Instrumentation, Technologies, Opportunities

This new 11-country report from VPGMarketResearch.com is available by country, market segment, section, or individual test....


 

$9500.00
       
Middle East Virology and Bacteriology Testing Market: Sales and Volume Forecasts for 100 Microbiology Tests, Competitive Strategies, Instrumentation, Technologies, Opportunities

This new 11-country report from VPGMarketResearch.com is available by country, market segment, section, or individual test....


 

$9500.00
       
Analysis of the Enteric Disease Testing Market in Europe:
Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia


This new 363-page report from Venture Planning Group provides analysis of the European enteric disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.

About this Report

This report presents detailed analysis of the Enteric Disease market in Europe (France, Germany, Italy, Spain, UK)....


 

$9400.00
       
Respiratory Diseases: Global Market Outlook and Emerging Opportunities

This 366-page report presents detailed analysis of the Respiratory Disease market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on epidemiology and etiology are provided for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis....

 

$9200.00
       
Global Hepatitis Diagnostics Market: Growth Opportunities and Business Expansion Strategies

This 320-page report presents a detailed analysis of the Hepatitis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed....


 

$8750.00
       
Sexually-Transmitted Diseases (STD): Global Market Outlook and Emerging Opportunities

This report presents detailed analysis of the STD market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on epidemiology and etiology are presented for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis....

 

$8500.00
       
Analysis of the Respiratory Disease Testing Market in Europe:
Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis


This new 335-page report from Venture Planning Group provides analysis of the European respiratory disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.

About this Report

This report presents detailed analysis of the Respiratory Disease market in Europe (France, Germany, Italy, Spain, UK)....


 

$8300.00
       
Analysis of the Sexually-Transmitted Disease Testing Market in Europe: Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, Syphilis

This new 318-page report from Venture Planning Group provides analysis of the European sexually-transmitted disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.

The report presents detailed analysis of the STD market in Europe (France, Germany, Italy, Spain, UK), Current scientific views on epidemiology and etiology are presented for Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, and Syphilis. The report provides test volume and sales forecasts by country and market segment, including:


 

$7900.00
       
Analysis of the European Hepatitis Diagnostics Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices--Supplier Shares and Sales Forecasts For 10 Immunodiagnostic and NAT Procedures

The report presents a detailed analysis of the Hepatitis diagnostics market in Europe, (France, Germany, Italy, Spain, UK). Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides the five-year test volume and sales forecasts by country for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets:

 

$6900.00
       
Hepatitis A, B, C, D, E Diagnostics Market: France, Germany, Italy, Spain, UK--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

The report presents a detailed analysis of the Hepatitis diagnostics market in Europe, (France, Germany, Italy, Spain, UK). Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides the five-year test volume and sales forecasts by country for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets:

 

$6900.00
       
Analysis of the US Hospital Infectious Disease
Testing Market


This new report from Venture Planning Group contains 997 pages, 87 tables, and presents a comprehensive analysis of the US hospital infectious disease testing market, including:



 

$6800.00
       
US Sales and Market Shares of Major Infectious Disease Testing Product Suppliers by Assay and Country

This unique report from Venture Planning Group provides US sales and market share estimates for major suppliers of infectious disease testing products by assay and country.

The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.


 

$6500.00
       
Analysis of the Japanese Hospital Infectious Disease
Testing Market


This new report from Venture Planning Group contains 891 pages, 75 tables, and presents a comprehensive analysis of the Japanese hospital infectious disease testing market, including:



 

$5800.00
       
The HIV/AIDS Diagnostics Market: US, Europe, Japan
Test Volumes, Sales Forecasts, and Supplier Shares by Country


This 7-country report presents detailed analyses of the AIDS diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. For each country, the report provides test volume and sales forecasts for HIV-1/2, HIV Ag, NAT, Western Blot and other confirmatory tests performed in the following market segments:



 

$4850.00
       
Innovative CMV Diagnostic Technologies and Emerging Markets

The report contains 231 pages, 15 tables and presents a detailed analysis of the Cytomegalovirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the CMV definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:

 

$4850.00
       
Innovative Herpes Diagnostic Technologies and Emerging Markets

The report contains 241 pages, 22 tables and presents a detailed analysis of the Herpes diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Herpes definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for Herpes Simplex I/II and Herpes Type VI testing for the following markets:

 

$4850.00
       
France Sales and Market Shares of Major Infectious Disease Testing Product Suppliers by Assay and Country

This unique report from Venture Planning Group provides France sales and market share estimates for major suppliers of infectious disease testing products by assay and country.

The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.


 

$4850.00
       
Japan Sales and Market Shares of Major Infectious Disease Testing Product Suppliers by Assay and Country

This unique report from Venture Planning Group provides Japan sales and market share estimates for major suppliers of infectious disease testing products by assay and country.

The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.


 

$4750.00
       
« Previous     1  2  3  4  5  6  7  8  9  10   Next »
 
VPGMarketResearch.com © Copyright 2015. all rights reserved. Web Design by Spida Design  
  Close  X